bf/NASDAQ:GTBP_icon.jpeg

NASDAQ:GTBP

GT Biopharma, Inc.

  • Stock

USD

Last Close

2.72

26/07 20:00

Market Cap

6.06M

Beta: 0.86

Volume Today

2.40K

Avg: 131.26K

PE Ratio

−15.25

PFCF: −19.13

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
368K
-
61K
83.42%
27K
55.74%
cost of revenue
226K
-
57K
74.78%
4K
-
gross profit
142K
-
4K
97.18%
27K
575%
-4K
-
selling and marketing expenses
general and administrative expenses
935K
-
12.49M
-
9.79M
21.60%
6.28M
35.86%
47.92M
663.24%
selling general and administrative expenses
935K
-
2.40M
156.68%
7.95M
231.42%
8.40M
5.59%
134.50M
1,501.40%
12.49M
90.72%
9.79M
21.60%
6.28M
35.86%
47.92M
663.24%
12.45M
74.03%
7.11M
42.87%
research and development expenses
1M
-
975K
2.50%
1.07M
9.54%
9.07M
748.97%
1.67M
81.61%
485K
70.91%
9.59M
1,877.53%
8.81M
8.13%
6.47M
26.61%
other expenses
-12.60M
-
-242.76K
98.07%
cost and expenses
1.16M
-
2.46M
111.63%
8.95M
264.43%
9.37M
4.69%
135.57M
1,346.23%
21.55M
84.10%
11.46M
46.85%
6.76M
40.96%
57.52M
750.31%
21.26M
63.04%
13.58M
36.13%
operating expenses
935K
-
2.40M
156.68%
8.95M
273.08%
9.37M
4.69%
135.57M
1,346.23%
21.55M
84.10%
11.46M
46.85%
6.76M
40.96%
57.52M
750.31%
21.26M
63.04%
13.58M
36.13%
interest expense
-1.20M
-
5.15M
530.27%
17.04M
231.11%
-6.55M
138.47%
-8.60M
31.23%
9.12M
205.99%
2.13M
76.66%
3.32M
56.02%
718K
78.37%
8K
98.89%
213K
2,562.50%
ebitda
-2.22M
-
-2.37M
7.13%
-8.93M
275.95%
-46.34M
419.16%
-136.49M
194.58%
-21.55M
84.21%
-11.45M
46.85%
-19.36M
69.06%
-57.48M
196.85%
-20.96M
63.52%
-13.58M
35.24%
operating income
-793K
-
-2.40M
202.14%
-8.93M
272.58%
-9.37M
5.01%
-135.57M
1,346.23%
-250.07M
84.46%
-16.06M
93.58%
-6.76M
57.87%
-57.52M
750.31%
-21.26M
63.04%
-13.58M
36.13%
depreciation and amortization
2K
-
22K
1,000%
2K
90.91%
1K
50%
2K
100%
7K
250%
4.60M
65,657.14%
-12.60M
373.69%
38K
100.30%
292K
668.42%
total other income expenses net
1.43M
-
-15.95M
1,219.09%
-6.76M
57.61%
36.96M
646.78%
925K
97.50%
-228.51M
24,804.32%
-22.59M
90.11%
-21.53M
4.69%
-498K
97.69%
373K
174.90%
5.98M
1,502.95%
income before tax
-564K
-
-23.49M
4,064.72%
-32.73M
39.32%
21.03M
164.27%
-143.25M
781.06%
-259.19M
80.94%
-38.65M
85.09%
-28.30M
26.78%
-58.01M
105.02%
-20.88M
64.00%
-7.60M
63.62%
income tax expense
-292K
-
5.15M
1,862.33%
17.04M
231.11%
-30.41M
278.46%
7.68M
125.25%
-228.51M
3,076.62%
2.13M
100.93%
3.32M
56.02%
680K
79.52%
-381K
156.03%
net income
-501K
-
-23.49M
4,588.42%
-32.73M
39.32%
21.03M
164.27%
-143.25M
781.06%
-259.19M
80.94%
-40.77M
84.27%
-31.62M
22.46%
-58.69M
85.64%
-20.50M
65.07%
-7.60M
62.95%
weighted average shs out
449
-
464
3.34%
470
1.29%
4.79K
919.36%
986.42K
20,489.00%
2.96M
199.60%
112.80K
96.18%
146.17K
29.59%
938.52K
542.07%
1.06M
13.19%
1.35M
26.87%
weighted average shs out dil
449
-
464
3.34%
470
1.29%
4.79K
919.36%
986.42K
20,489.00%
2.96M
199.60%
112.80K
96.18%
146.17K
29.59%
938.52K
542.07%
1.06M
13.19%
1.35M
26.87%
eps
-1.12K
-
-50.62K
4,436.87%
-69.63K
37.55%
2.04K
102.93%
-145.22
107.12%
-87.70
39.61%
-361.49
312.19%
-216.29
40.17%
-62.54
71.09%
-19.30
69.14%
-5.64
70.78%
epsdiluted
-1.12K
-
-50.62K
4,436.87%
-69.63K
37.55%
2.04K
102.93%
-145.22
107.12%
-87.70
39.61%
-361.49
312.19%
-216.29
40.17%
-62.54
71.09%
-19.30
69.14%
-5.64
70.78%

All numbers in USD (except ratios and percentages)